首页> 外文OA文献 >Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management
【2h】

Current Status of Research on Osteoporosis after Solid Organ Transplantation: Pathogenesis and Management

机译:固体器官移植后骨质疏松症研究现状:发病机制与管理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Improved survival following organ transplantation has brought to the forefront some long-term complications, among which osteoporosis and associated fractures are the major ones that adversely affect the quality of life in recipients. The pathogenesis of osteoporosis in transplant recipients is complex and multifactorial which may be related to increased bone resorption, decreased bone formation, or both. Studies have shown that the preexisting underlying metabolic bone disorders and the use of immunosuppressive agents are the major risk factors for osteoporosis and fractures after organ transplantation. And rapid bone loss usually occurs in the first 6–12 months with a significant increase in fracture risk. This paper will provide an updated review on the possible pathogenesis of posttransplant osteoporosis and fractures, the natural history, and the current prevention and treatment strategies concerning different types of organ transplantation.
机译:改善器官移植后的存活率已经引起了一些长期并发症,其中骨质疏松症和相关的骨折是对接受者生活质量产生不利影响的主要原因。移植受体中骨质疏松症的发病机制是复杂的和多方面,其可能与增加的骨吸收,骨形成减少或两者有关。研究表明,预先存在的潜在代谢骨障碍和免疫抑制剂的使用是器官移植后骨质疏松症和骨折的主要危险因素。快速骨质损失通常发生在前6-12个月内,骨折风险显着增加。本文将对药片骨折骨质疏松症和骨折,自然历史和当前预防和治疗策略的可能发病机制提供更新的审查,以及关于不同类型的器官移植的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号